Drug intelligence / Profile preview

dequalinium

Development stage
Phase 4
Modality
Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Topical, Intravaginal
01

Overview

Dequalinium is a quaternary ammonium cation antimicrobial agent with broad-spectrum activity against gram-positive and gram-negative bacteria, yeasts (including Candida), fungi, protozoa (such as Trichomonas), and some viruses. It is commonly used as an antiseptic and disinfectant in the form of lozenges for oral infections (such as sore throat, tonsillitis, stomatitis) and as vaginal tablets for bacterial vaginosis and other vaginal infections[1][3][5]. Dequalinium acts by increasing microbial cell membrane permeability leading to loss of enzyme activity; it denatures proteins involved in the respiratory chain and glycolysis within bacteria—disrupting metabolism—and can intercalate into DNA causing precipitation of nucleic acids[1][6][8]. It also inhibits bacterial F1-ATPase affecting ATP synthesis. The compound has been investigated for additional properties including antifungal, antiparasitic, antiviral effects as well as anticancer and neuroprotective actions[1][4]. First introduced in the 1950s as an antiseptic/disinfectant agent.

Brand names
DequadinFluomizinVablysNaxyl
Other names
dequalinium chloridedequalinium acetatedequalinium bromidedequalinium iodideDQC
02

Targets

CNGA1 (Cyclic nucleotide-gated channel alpha 1)PKC (Protein kinase C family)

Beyond the preview

Go deeper on dequalinium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dequalinium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call